- Home
- CREV vs SNOA Comparison
CREV vs SNOA Comparison
Compare CREV & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREV
- SNOA
- Stock Information
- Founded
- CREV 2007
- SNOA 1999
- Country
- CREV Ireland
- SNOA United States
- Employees
- CREV N/A
- SNOA N/A
- Industry
- CREV
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- CREV
- SNOA Health Care
- Exchange
- CREV Nasdaq
- SNOA Nasdaq
- Market Cap
- CREV 5.7M
- SNOA 6.4M
- IPO Year
- CREV N/A
- SNOA 2007
- Fundamental
- Price
- CREV $3.10
- SNOA $3.47
- Analyst Decision
- CREV
- SNOA
- Analyst Count
- CREV 0
- SNOA 0
- Target Price
- CREV N/A
- SNOA N/A
- AVG Volume (30 Days)
- CREV 424.0K
- SNOA 70.1K
- Earning Date
- CREV 05-14-2025
- SNOA 06-16-2025
- Dividend Yield
- CREV N/A
- SNOA N/A
- EPS Growth
- CREV N/A
- SNOA N/A
- EPS
- CREV N/A
- SNOA N/A
- Revenue
- CREV $39,261,077.00
- SNOA $13,973,000.00
- Revenue This Year
- CREV $40.76
- SNOA $23.89
- Revenue Next Year
- CREV $86.18
- SNOA $25.45
- P/E Ratio
- CREV N/A
- SNOA N/A
- Revenue Growth
- CREV 41.52
- SNOA 13.51
- 52 Week Low
- CREV $2.00
- SNOA $1.75
- 52 Week High
- CREV $14.19
- SNOA $9.37
- Technical
- Relative Strength Index (RSI)
- CREV 48.08
- SNOA 59.16
- Support Level
- CREV $2.95
- SNOA $3.05
- Resistance Level
- CREV $3.50
- SNOA $3.41
- Average True Range (ATR)
- CREV 0.35
- SNOA 0.20
- MACD
- CREV -0.02
- SNOA -0.00
- Stochastic Oscillator
- CREV 37.10
- SNOA 79.31
About CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.